depression

J&J prices ketamine-like depression treatment at $590-$885 for two doses
Reuters
Fri, 03/8/19 - 09:35 am
JNJ
Spravato
depression
drug pricing
esketamine
2 Biotech Stocks With Major Incoming Catalysts
Yahoo/Motley Fool
Thu, 03/7/19 - 09:52 am
Axsome Therapeutics
AXS-05
depression
Galapagos
filgotinib
Gilead Sciences
rheumatoid arthritis
[video+transcript]Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A
Motley Fool
Fri, 11/9/18 - 12:05 am
Alkermes
depression
ALSK-5461
opioids
Illumina
Pacific Biosciences
Ketamine is emerging as a popular treatment for depression. New research suggests the drug acts like an opioid
CNBC
Wed, 08/29/18 - 10:31 am
depression
ketamine
opioids
JNJ
Allergan
Diagnosing Depression By Blood Biomarkers: A Viable Approach?
Forbes
Tue, 07/31/18 - 10:21 am
depression
biomarkers
diagnostics
Nano Vision
Gut Microbes Associated With Obesity May Contribute to Depression and Anxiety
CP Wire
Mon, 06/18/18 - 11:15 am
microbiome
obesity
anxiety
depression
Gut Microbes Associated With Obesity May Contribute to Depression and Anxiety
Mon, 06/18/18 - 10:55 am
microbiome
depression
anxiety
On a roll, Sage grabs a $575M deal on limited Asian rights to SAGE-217 — a potential gamechanger in depression
Endpoints
Wed, 06/13/18 - 09:48 pm
SAGE Therapeutics
SAGE-217
Asia
Shionogi
depression
Neuronetics files for $86m IPO
Mass Device
Fri, 06/1/18 - 10:03 am
Neuronetics
devices
IPOs
depression
Can precision medicine do for depression what it’s done for cancer? It won’t be easy
Stat
Wed, 05/9/18 - 09:33 pm
depression
precision medicine
J&J’s Janssen touts Ph3 data for antidepressant nasal spray
Drug Delivery Business News
Mon, 05/7/18 - 09:37 am
JNJ
Janssen
esketamine
depression
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study
CP Wire
Mon, 04/16/18 - 04:11 pm
JNJ
esketamine
depression
major depression
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study
Mon, 04/16/18 - 04:10 pm
JNJ
esketamine
depression
major depression
FDA Rejects Alkermes NDA for Major Depressive Disorder Drug ALKS 5461
CP Wire
Mon, 04/2/18 - 09:01 am
Alkermes
FDA
depression
major depressive disorder
ALKS 5461
Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma
24/7 Wall St
Sat, 10/22/16 - 03:30 pm
Alkermes
depression
suicide
suicidal ideation
ALKS 5461
Pfizer's quit-smoking drug not linked to depression or heart risks
Yahoo/Reuters
Mon, 09/7/15 - 11:34 am
Pfizer
Chantix
smoking cessation
heart attacks
depression
Antidepressant Use Has Exploded Since 1988
Yahoo/Business Insider
Wed, 05/14/14 - 08:36 am
antidepressants
depression
Corcept Therapeutics stops depression drug trial
Yahoo/AP
Wed, 05/7/14 - 09:48 am
Corcept Therapeutics
depression
psychotic depression
Chantix Does Not Increase Depression Risk? A Pfizer Study Says Yes
Pharmalot
Wed, 09/18/13 - 10:15 am
Chantix
Pfizer
depression
smoking cessation
Albany Molecular says Bristol-Myers stops developing depression drug
Reuters
Mon, 08/12/13 - 05:01 pm
Albany Molecular Research
Bristol-Myers Squibb
BMS-820836
treatment-resistant depression
depression

Pages